Sumitomo Chemical India Ltd
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]
- Market Cap ₹ 20,934 Cr.
- Current Price ₹ 419
- High / Low ₹ 541 / 395
- Stock P/E 41.4
- Book Value ₹ 44.4
- Dividend Yield 0.24 %
- ROCE 33.7 %
- ROE 25.1 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 47.7% CAGR over last 5 years
Cons
- Stock is trading at 9.44 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
229 | 451 | 495 | 635 | 671 | 724 | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,064 | 3,526 | |
250 | 463 | 484 | 587 | 614 | 635 | 698 | 1,691 | 1,932 | 2,088 | 2,155 | 2,461 | 2,830 | |
Operating Profit | -21 | -12 | 10 | 48 | 57 | 89 | 101 | 219 | 291 | 335 | 488 | 603 | 696 |
OPM % | -9% | -3% | 2% | 8% | 8% | 12% | 13% | 11% | 13% | 14% | 18% | 20% | 20% |
1 | 1 | 3 | 3 | 8 | 26 | 10 | 31 | -0 | -20 | 19 | 36 | 36 | |
Interest | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 5 |
Depreciation | 0 | 0 | 0 | 6 | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 49 |
Profit before tax | -20 | -11 | 13 | 43 | 58 | 107 | 103 | 221 | 258 | 267 | 453 | 586 | 678 |
Tax % | 0% | 0% | 0% | 23% | 40% | 40% | 40% | 34% | 35% | 23% | 24% | 26% | |
Net Profit | -20 | -11 | 13 | 33 | 35 | 65 | 62 | 145 | 167 | 206 | 345 | 434 | 506 |
EPS in Rs | 4.12 | 6.92 | 8.69 | 10.14 | |||||||||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 38% | 18% | 12% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 21% |
5 Years: | 31% |
3 Years: | 11% |
TTM: | 20% |
Compounded Profit Growth | |
---|---|
10 Years: | 46% |
5 Years: | 48% |
3 Years: | 36% |
TTM: | 22% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 36% |
1 Year: | -1% |
Return on Equity | |
---|---|
10 Years: | 21% |
5 Years: | 22% |
3 Years: | 24% |
Last Year: | 25% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
136 | 233 | 233 | 233 | 233 | 233 | 275 | 275 | 275 | 499 | 499 | 499 | 499 | |
Reserves | -72 | -82 | -70 | -36 | -2 | 63 | 360 | 665 | 761 | 710 | 1,029 | 1,425 | 1,718 |
52 | 0 | 1 | 0 | 0 | 0 | 0 | 10 | 20 | 36 | 33 | 38 | 32 | |
68 | 208 | 202 | 243 | 234 | 280 | 288 | 695 | 791 | 848 | 1,097 | 1,047 | 1,206 | |
Total Liabilities | 185 | 359 | 367 | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,455 |
10 | 53 | 48 | 47 | 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 431 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 7 | 9 | 8 | 10 | 14 | 35 | 23 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 277 | 2 | 1 | 87 | 291 | 357 | 312 |
175 | 306 | 319 | 393 | 415 | 523 | 585 | 1,367 | 1,558 | 1,676 | 2,043 | 2,227 | 2,689 | |
Total Assets | 185 | 359 | 367 | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,455 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-8 | 75 | -16 | 20 | 4 | 52 | -21 | 49 | 75 | 222 | 424 | 223 | |
-0 | -2 | -1 | -8 | -8 | -5 | -289 | -40 | -35 | -118 | -282 | -281 | |
8 | -49 | 0 | -1 | 0 | -0 | 276 | 7 | -65 | -61 | -47 | -63 | |
Net Cash Flow | 0 | 24 | -17 | 11 | -4 | 47 | -34 | 16 | -26 | 43 | 95 | -120 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 138 | 105 | 96 | 90 | 83 | 92 | 101 | 105 | 110 | 128 | 117 | 100 |
Inventory Days | 125 | 135 | 169 | 191 | 202 | 193 | 133 | 185 | 198 | |||
Days Payable | 134 | 109 | 132 | 115 | 176 | 136 | 112 | 145 | 110 | |||
Cash Conversion Cycle | 138 | 105 | 96 | 81 | 109 | 130 | 177 | 131 | 167 | 150 | 157 | 189 |
Working Capital Days | 156 | 42 | 62 | 58 | 69 | 79 | 113 | 115 | 119 | 111 | 97 | 128 |
ROCE % | -8% | 8% | 25% | 27% | 41% | 22% | 29% | 27% | 26% | 33% | 34% |
Documents
Announcements
- Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 19 Mar
-
Delhi High Court Order On Government Notification Restricting Use Of Glyphosate
14 Mar - Has reference to our Letter Ref: SCIL/SEC/2022 dated 26th November, 2022, whereby we had intimated you that, at the hearing held on 23rd November, 2022, …
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
4 Mar - Has reference to our letter dated 25th February, 2023 as submitted to the Stock Exchanges on an accident at the Bhavnagar Site of the Company …
- Release Of Lock-In Of The Shares Held By The Promoters Of The Company. 1 Mar
- Accident At The Company'S Bhavnagar Site 25 Feb
Annual reports
Concalls
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
Products
The Company has a presence in all the product segments - insecticides, weedicides, fungicides, fumigants and rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. The Company is known for domestic marketing of proprietary products of its Japanese parent – Sumitomo Chemical Company, Limited in agrochemicals, animal nutrition, and environmental health business segments. [1]
The products comprise conventional chemistry sourced from the parent company, SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC, a leader in producing a range of naturally occurring, environmentally compatible pesticides and plant growth regulators, for over 40 years. [2]